Pathstone Family Office’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$413K Buy
6,983
+3,093
+80% +$161K ﹤0.01% 1137
2023
Q2
$212K Sell
3,890
-160
-4% -$8.6K ﹤0.01% 1118
2023
Q1
$272K Sell
4,050
-2,402
-37% -$189K ﹤0.01% 956
2022
Q4
$500K Buy
6,452
+540
+9% +$40.2K ﹤0.01% 1098
2022
Q3
$510K Buy
5,912
+3,023
+105% +$287K ﹤0.01% 1072
2022
Q2
$255K Hold
2,889
0.01% 864
2022
Q1
$412K Sell
2,889
-3,010
-51% -$379K 0.01% 622
2021
Q4
$991K Buy
5,899
+68
+1% +$10.5K 0.02% 341
2021
Q3
$792K Buy
5,831
+318
+6% +$41.1K 0.02% 361
2021
Q2
$625K Buy
5,513
+2,002
+57% +$194K 0.02% 400
2021
Q1
$297K Buy
+3,511
New +$293K 0.01% 488

Other funds holding DAVA

Pathstone Family Office's DAVA Position: Q3 2023 in Review

Pathstone Family Office increased its Endava (DAVA) stake by 80% in Q3 2023, buying an estimated $161K and bringing the position to 6,983 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Pathstone Family Office first reported a position in DAVA in Q1 2021 and has held it in 11 quarters since. The position peaked at $991K in Q4 2021. 154 funds tracked by Wall St. Rank hold DAVA as of Q3 2023.

  • Pathstone Family Office held 6,983 shares of Endava worth $413K as of Q3 2023.
  • Pathstone Family Office bought 3,093 Endava shares in Q3 2023, an estimated $161K.
  • Endava made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1137 holding.
  • Pathstone Family Office first reported a position in Endava in Q1 2021 and has held it in 11 quarters since.
  • Pathstone Family Office's Endava position peaked at $991K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held Endava as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.